You are here

  • Home
  • Archive
  • Volume 72, Issue 9
  • Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Genovese MC, Fleischmann RM, Greenwald M, et al
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors
Annals of the Rheumatic Diseases 2013;72:1461-1468.